Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Harvoni
Harvoni
Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead
Fierce Pharma
Tue, 01/19/21 - 09:18 pm
Merck
Idenis
Gilead Sciences
patents
Harvoni
Sovaldi
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
market exclusivity
patents
Rituxan
Lyrica
Herceptin
Avastin
Epclusa
Harvoni
Pfizer
Roche
Gilead Sciences
Amgen
GSK
Allergan
Individor
China approves Descovy, Harvoni, Hemlibra
BioCentury
Tue, 12/4/18 - 11:51 pm
China
Harvoni
Descovy
Hemlibra
Roche
Gilead Sciences
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
CP Wire
Mon, 09/24/18 - 09:34 am
Gilead Sciences
generics
Epclusa
Harvoni
hepatitis C
Asegua Therapeutics
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
Mon, 09/24/18 - 09:22 am
Gilead
Epclusa
Harvoni
Gilead wins reprieve in Merck's $2.5B patent lawsuit
Biopharma Dive
Thu, 02/22/18 - 09:52 am
Gilead Sciences
Merck
patents
Sovaldi
Harvoni
hepatitis C
Idenix
Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
Reuters
Sun, 02/18/18 - 10:10 am
Gilead Sciences
hepatitis C
patents
Merck
Sovaldi
Harvoni
Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short
Fierce Pharma
Thu, 02/8/18 - 09:14 am
AbbVie
Mavyret
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
The 1 Thing Missing From Gilead Sciences' 2018 Priority List
Motley Fool
Tue, 11/21/17 - 10:37 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Epclusa
How can new launches mimic Keytruda, Harvoni, and Opdivo? A new report has some ideas
Fierce Pharma
Thu, 11/16/17 - 11:27 am
drug launches
Keytruda
Harvoni
Opdivo
Merck
Bristol-Myers Squibb
Gilead Sciences
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
Investors Business Daily
Wed, 07/19/17 - 07:55 pm
AbbVie
Gilead Sciences
hepatitis C
Vosevi
Harvoni
Sovaldi
Epclusa
Viekira Pak
When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs
Forbes
Wed, 07/19/17 - 09:58 am
drug pricing
hepatitis C
Martin Shkreli
Gilead Sciences
Harvoni
Sovaldi
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Gilead works on lifecycle management for Sovaldi as Hep C franchise wanes
BioPharma Dive
Thu, 04/13/17 - 11:48 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead Hep C Drugs Get Supplemental FDA Nod
Investopedia
Sat, 04/8/17 - 01:11 pm
Gilead Sciences
hepatitis C
FDA
Harvoni
Sovaldi
Gilead's Harvoni ads go from before to after with new creative focused on hep C cure
Fierce Pharma
Wed, 03/29/17 - 10:40 pm
Gilead Sciences
Harvoni
drug ads
DTC ads
hepatitis C
Gilead pushes hep C testing in baby boomers as its blockbusters plummet
Fierce Pharma
Thu, 02/23/17 - 09:21 am
Gilead Sciences
hepatitis C
baby boomers
DTC advertising
Harvoni
Sovaldi
Gilead cured hepatitis C. That’s become its biggest problem
Marketwatch
Wed, 02/8/17 - 09:27 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns
Bloomberg
Wed, 02/8/17 - 09:21 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Motley Fool
Mon, 01/23/17 - 10:26 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Pages
1
2
3
4
5
6
7
8
9
next ›
last »